184 related articles for article (PubMed ID: 29296018)
1. Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis.
Awad MA; Gaither TW; Osterberg EC; Murphy GP; Baradaran N; Breyer BN
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):168-174. PubMed ID: 29296018
[TBL] [Abstract][Full Text] [Related]
2. The dosimetry of prostate brachytherapy-induced urethral strictures.
Merrick GS; Butler WM; Tollenaar BG; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):461-8. PubMed ID: 11872293
[TBL] [Abstract][Full Text] [Related]
3. Urethral stricture following high dose rate brachytherapy for prostate cancer.
Sullivan L; Williams SG; Tai KH; Foroudi F; Cleeve L; Duchesne GM
Radiother Oncol; 2009 May; 91(2):232-6. PubMed ID: 19097660
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on dosimetric and radiomics analysis of urethral strictures following HDR brachytherapy as monotherapy for localized prostate cancer.
Tsang YM; Vignarajah D; Mcwilliam A; Tharmalingam H; Lowe G; Choudhury A; Hoskin P
Br J Radiol; 2020 Feb; 93(1106):20190760. PubMed ID: 31778319
[TBL] [Abstract][Full Text] [Related]
5. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the development of prostate brachytherapy related urethral strictures.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Allen ZA; Adamovich E
J Urol; 2006 Apr; 175(4):1376-80; discussion 1381. PubMed ID: 16516001
[TBL] [Abstract][Full Text] [Related]
7. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
Jarosek SL; Virnig BA; Chu H; Elliott SP
Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Incontinence Rates After Urethroplasty for Radiation-induced Urethral Stenosis: A Systematic Review and Meta-analysis.
Sapienza LG; Ning MS; Carvalho EF; Spratt D; Calsavara VF; McLaughlin PW; Gomes MJL; Baiocchi G; Abu-Isa E
Urology; 2021 Jun; 152():109-116. PubMed ID: 33631205
[TBL] [Abstract][Full Text] [Related]
9. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer.
Khor R; Duchesne G; Tai KH; Foroudi F; Chander S; Van Dyk S; Garth M; Williams S
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):679-85. PubMed ID: 22954770
[TBL] [Abstract][Full Text] [Related]
10. Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiation therapy.
McDonald AM; Baker CB; Popple RA; Cardan RA; Fiveash JB
Pract Radiat Oncol; 2015; 5(5):338-342. PubMed ID: 25858771
[TBL] [Abstract][Full Text] [Related]
11. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
[TBL] [Abstract][Full Text] [Related]
12. [Urethral stricture rate after prostate cancer radiotherapy : Five-year data of a certified prostate cancer center].
Kranz J; Maurer G; Maurer U; Deserno O; Schulte S; Steffens J
Urologe A; 2017 Mar; 56(3):336-341. PubMed ID: 28102436
[TBL] [Abstract][Full Text] [Related]
13. Urethroplasty after radiation therapy for prostate cancer.
Glass AS; McAninch JW; Zaid UB; Cinman NM; Breyer BN
Urology; 2012 Jun; 79(6):1402-5. PubMed ID: 22521189
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for urethral stricture following external beam radiotherapy and HDR brachytherapy for prostate cancer.
Groom N; Tsang Y; Lowe G; Hoskin P
Brachytherapy; 2021; 20(2):302-306. PubMed ID: 33234408
[TBL] [Abstract][Full Text] [Related]
16. Two decades of high dose rate brachytherapy with external beam radiotherapy for prostate cancer.
Åström L; Grusell E; Sandin F; Turesson I; Holmberg L
Radiother Oncol; 2018 Apr; 127(1):81-87. PubMed ID: 29496280
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric analysis of urethral strictures following HDR (192)Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer.
Díez P; Mullassery V; Dankulchai P; Ostler P; Hughes R; Alonzi R; Lowe G; Hoskin PJ
Radiother Oncol; 2014 Dec; 113(3):410-3. PubMed ID: 25544648
[TBL] [Abstract][Full Text] [Related]
18. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
19. Urethral pain among prostate cancer survivors 1 to 14 years after radiation therapy.
Pettersson N; Olsson C; Tucker SL; Alsadius D; Wilderäng U; Johansson KA; Steineck G
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e29-37. PubMed ID: 23237005
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
